Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Tailored and Targeted Pharmaceutical Marketing

October 10, 2023 |  

Learn more about targeted personas for HCP marketing.    If pharma companies want to differentiate themselves against their competition and produce impactful results they must be much bolder than the current state of play. True, intentional marketing, tailored meaningfully to all of your target audience.    REVOLUTIONISING PHARMA COMMS is an imperative. Learn how scalable and responsive content provision can maximise engagement driven by intelligent data. Serve your content to hundreds and thousands of doctors, each and every time, in a way that is efficient, repeatable, transparent and structured. For the first time, pharmaceutical companies have a tool that allows them to personalise customer journeys at scale, extending the impact of bespoke marketing strategies beyond doctors in their CRMs, to new portions of the market.

This content was provided by M3 (EU)

Documents for download:

Company Details

- PMLiVE

M3 (EU)

Email
Website

 Latest Content from  M3 (EU) 

The evolving world of pharma: trends challenges and opportunities

M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets are shrinking, targets are climbing, and compliance requirements are getting…

Tailored and Targeted Pharmaceutical Marketing

Learn more about targeted personas for HCP marketing.    If pharma companies want to differentiate themselves against their competition and produce impactful results they must be much bolder than the current state…

Learning to invest in doctors’ education

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for…

Engaging doctors around the globe

Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies…

How do doctors spend their time online?

In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.

How do doctors want to engage with pharma on new products?

More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they…

M3 Acquires MirVracha LCC in Russia Launching Full-Scale Development of Physician Platform Business in Russia

M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/; “M3” below) has announced the acquisition of MirVracha LCC (Headquarters: Moscow, Russia; CEO: Shotaro Yamamoto; “MirVracha” below), a website provider…

Revolutionising the Digital Content Delivery Model

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver…

Healthcare in the Digital Age

Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.

M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group

M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs…